Published in Xenotransplantation on September 01, 2002
Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals. PLoS One (2011) 0.93
Bridging innate and adaptive antitumor immunity targeting glycans. J Biomed Biotechnol (2010) 0.84
Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation. Transpl Int (2012) 0.77
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol (2002) 3.32
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol (2003) 2.72
Primary antitumor immune response mediated by CD4+ T cells. Immunity (2005) 2.72
Rewarming after hypothermia after cardiac arrest shifts the inflammatory balance. Crit Care Med (2012) 2.26
Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology (2006) 2.04
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med (2004) 1.92
Biological implications of cell fusion. Nat Rev Mol Cell Biol (2005) 1.87
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant (2003) 1.86
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology (2008) 1.79
Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann Neurol (2009) 1.76
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol (2008) 1.76
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol (2006) 1.68
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol (2004) 1.62
Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood (2004) 1.61
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood (2010) 1.56
Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J (2008) 1.56
Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res (2002) 1.56
A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J Exp Med (2005) 1.54
Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery. Ann Thorac Surg (2008) 1.52
Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood (2004) 1.50
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun (2011) 1.49
Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. J Am Coll Cardiol (2007) 1.48
Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48
New technologies for organ replacement and augmentation. Mayo Clin Proc (2005) 1.48
Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol (2003) 1.47
Xenotransplantation and the future of renal replacement. J Am Soc Nephrol (2004) 1.47
Conditional signaling by Toll-like receptor 4. FASEB J (2005) 1.42
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J Hepatol (2006) 1.42
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Immunosuppression by embryonic stem cells. Stem Cells (2007) 1.38
An international serum standard for application in assays to detect human complement activation products. Mol Immunol (2013) 1.34
Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol (2009) 1.27
Accommodation: preventing injury in transplantation and disease. J Immunol (2004) 1.25
The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies. J Leukoc Biol (2009) 1.25
Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation. Am J Transplant (2005) 1.23
Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology (2009) 1.23
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol (2010) 1.21
The double-edged sword of activation-induced cytidine deaminase. J Immunol (2005) 1.20
Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. J Immunol (2005) 1.20
Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol (2005) 1.19
B cell-dependent TCR diversification. J Immunol (2004) 1.18
Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation (2008) 1.17
Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol (2014) 1.15
A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant (2008) 1.14
Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha. Mol Cell Biol (2003) 1.14
Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood (2003) 1.14
The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J Leukoc Biol (2007) 1.11
Immunogenetics as a tool in anthropological studies. Immunology (2011) 1.11
Fitness of cell-mediated immunity independent of repertoire diversity. J Immunol (2007) 1.11
Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem (2002) 1.09
Selective activation of TACI by syndecan-2. Blood (2005) 1.09
Accommodation in organ transplantation. Curr Opin Organ Transplant (2008) 1.08
Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation (2004) 1.08
Acute renal failure early after heart transplantation: risk factors and clinical consequences. Clin Transplant (2010) 1.07
Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation (2003) 1.07
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol (2008) 1.06
A genetic basis for the "Adonis" phenotype of low adiposity and strong bones. FASEB J (2004) 1.05
ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation (2003) 1.04
LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels. Am J Pathol (2011) 1.04
Accommodation of grafts: implications for health and disease. Hum Immunol (2007) 1.04
Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol (2003) 1.03
Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. Chest (2010) 1.03
Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients. Ann Thorac Surg (2008) 1.02
C4d and the fate of organ allografts. J Am Soc Nephrol (2002) 1.01
Infection-induced proteolysis of PGRP-LC controls the IMD activation and melanization cascades in Drosophila. FASEB J (2008) 1.01
Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood (2005) 1.01
Effacing of the T cell compartment by cardiac transplantation in infancy. J Immunol (2006) 1.00
TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow. Blood (2011) 1.00
Spontaneous fusion of cells between species yields transdifferentiation and retroviral transfer in vivo. FASEB J (2004) 0.99
The etiology of sepsis: turned inside out. Trends Mol Med (2005) 0.98
Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol (2007) 0.98
Direct measurement of lymphocyte receptor diversity. Nucleic Acids Res (2003) 0.98
Short-term immunosuppression and surgical neoangiogenesis with host vessels maintains long-term viability of vascularized bone allografts. J Orthop Res (2007) 0.98
Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4. FEBS Lett (2005) 0.97
Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer (2006) 0.97
Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Clin Cancer Res (2003) 0.96
Propagation and control of T cell responses by heparan sulfate-bound IL-2. J Immunol (2003) 0.96
Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J (2004) 0.96
Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice. Am J Pathol (2002) 0.95
The alarmin IL-33 is a notch target in quiescent endothelial cells. Am J Pathol (2012) 0.94
Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Mol Immunol (2006) 0.94
Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. BMC Med Genet (2007) 0.93
T cell recognition and immunity in the fetus and mother. Cell Immunol (2007) 0.92
The paradoxical functions of B cells and antibodies in transplantation. J Immunol (2013) 0.92
Complement-dependent control of teratoma formation by embryonic stem cells. J Immunol (2006) 0.91
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells. Arterioscler Thromb Vasc Biol (2012) 0.91
Pathway-specific complement activity in pigs evaluated with a human functional complement assay. Mol Immunol (2009) 0.90
Membrane barrier of a porcine hepatocyte bioartificial liver. Liver Transpl (2003) 0.90
Intrinsic resistance of hepatocytes to complement-mediated injury. J Immunol (2005) 0.90
ALCAPA, a possible reason for mitral insufficiency and heart failure in young patients. Scand Cardiovasc J (2007) 0.89
Differential regulation of endothelial cell activation by complement and interleukin 1alpha. Circ Res (2006) 0.89
Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Gastroenterology (2006) 0.89